Asia-Pacific Minimally Invasive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The Asia-Pacific minimally-invasive surgery devices market is expected to register a CAGR of 7.1%, over the forecast period. The major factors for the growth of the Asia-Pacific minimally-invasive surgery devices market include increasing prevalence of lifestyle-related and chronic disorders, and technological advancements.
Minimally-invasive surgeries (MIS) cause less post-operative pain, and patients receive smaller dosages of pain killers. As there are minimal cuts or stitches involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. Moreover, advantage of minimally-invasive surgeries (MIS) over the traditional open surgeries include it produces a better and magnified image of the organs or body parts being operated and higher precision due to video-assisted equipment.
Moreover, as per Australian Bureau of Statistics 2019, Coronary heart disease is the leading cause of death in Australia. Heart disease represents one in five of all deaths in Australia. In Australia, approximately 1,100 people hospitalised every day due to heart diseases. Thus, owing to the benefits associated with minimally-invasive surgeries along with growing chronic diseases, which may increase the overall growth of the market over the forecast period.
Key Market TrendsGastrointestinal Segment, under Application, is expected to be the Grow Significantly over the Forecast Period.The major factors driving the growth of the gastrointestinal segment is rising incidence of gastrointestinal diseases in the young, adult, and geriatric groups. Dyspepsia, irritable-bowel syndrome, and constipation are some of the examples of gastrointestinal disorders. Gastroesophageal reflux disease is also a prevalent form of the organic gastrointestinal disorder. Minimally-invasive surgery has gained popularity for benign diseases, and has proved its safety and efficacy over traditional methods, owing to which, it has gained substantial attention in the past several years.
Japan has the world’s fastest ageing population. According to the World Ageing 2019 report, estimates that number of population who are above 65 years of age in Japan was 35.524 million (28%) in 2019 which is projected to reach 37.278 million (30.9%) in 2030. As number of geriatric population is expected to increase in coming years who are more prone to chronic diseases such as gastrointestinal diseases which ultimately rises the growth of market in near future. Thus, owing to above mentioned factors it is expected to show significant growth over the forecast period.
Competitive LandscapeThe Asia-Pacific Minimally Invasive Surgery Devices Market is consolidated, owing to the presence of a few key players in the market. Some of the market players are Abbott Laboratories, GE Healthcare, Intuitive Surgical Inc., Koninklijke Philips NV, Medtronic PLC, Olympus Corporation, Siemens Healthineers, Smith & Nephew, Stryker Corporation, and Zimmer Biomet.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook